Page 47 - 2020Taiwan Food and Drug Administration Annual Report

of western medicines and pharmacy operators who have obtained a drug license for western
medicine preparations should fulfill the regulations in the “Western Pharmaceuticals Good
Distribution Practice Regulations,´ VWDUWLQJ IURP -DQXDU\ 7KLV LV WKH ¿UVW VWDJH RI *'3
timeline.
The Ministry of Health and Welfare continued to implement the second stage of GDP
timeline. On May 10, 2019, it was announced that pharmacy operators of western medicine
SUHSDUDWLRQV ZKR UHTXLUH FROG FKDLQ VWRUDJH DQG WUDQVSRUWDWLRQ VKRXOG IXO¿OO WKH UHJXODWLRQV LQ
the “Western Pharmaceuticals Good Distribution Practice Regulations,” starting from January 1,

2022.

III. Implemented the GDP related supplementary measures
TFDA has progressively promoted the distribution and management system of western
medicines since 2011 and provided consultation and educational training to the business
operators in the industry, including continuing to conduct topic forums, technical seminars, and
OHVVRQ IRU SKDUPDFHXWLFDO ¿UPV 7)'$ DOVR LQYLWHG *'3 H[SHUWV WR SURYLGH RQ VLWH FRXQVHOLQJ
TFDA actively communicate with the industry to promote related management policies, and
WLPHOLQH DQG UHDFKHG D FRQVHQVXV ZH FUHDWHG D 3,& 6 *'3 DUHD RQ WKH RI¿FLDO ZHEVLWH RI 7)'$
and announce the GDP regulations to be used as a reference for the business operators.

$FKLHYHPHQWV DQG %HQH¿WVFKLHYHPHQWV DQG %HQH¿WV
$

As of the end of 2019, 691 western pharmaceutical manufacturers and pharmacy operators
KDYH IXO¿OOHG WKH *'3 VWDQGDUG ZKLFK KDV DWWDLQHG RI WKH ¿UPV LQ WKH ¿UVW VWDJH WR HQVXUH
the quality of drug storage and transportation as well as the quality and safety of the public’s
drugs usage.

4FDUJPO c"DUJWFMZ 1BSUJDJQBUF JO *OUFSOBUJPOBM &WFOUT PG .FEJDJOF

Introduction of the Policy
y
Introduction of the Polic
TFDA continues to promote international cooperation in pharmaceutical products in order to
HQKDQFH WKH LQWHUQDWLRQDO SDUWLFLSDWLRQ DQG LQÀXHQFH RI 7DLZDQ¶V SKDUPDFHXWLFDO DGPLQLVWUDWLRQ
TFDA actively participates in important international organization activities, such as the Asia-
Pacific Economic Cooperation (APEC) and The International Council for Harmonisation of
Technical Requirements for Pharmaceuticals for Human Use (ICH), Pharmaceutical Inspection
Co-operation Scheme (PIC/S) and strive to hold relevant international conferences in Taiwan, to
strengthen the bilateral and multilateral cooperation through interaction and experience sharing
with international regulatory institutions.

45